RBC Capital Maintains Outperform on Repligen, Raises Price Target to $195
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Conor McNamara maintains an Outperform rating on Repligen (NASDAQ:RGEN) and raises the price target from $157 to $195.

August 04, 2023 | 1:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital maintains an Outperform rating on Repligen and raises the price target from $157 to $195, indicating a positive outlook for the stock.
The raised price target by RBC Capital indicates their belief in the company's potential for growth. This could lead to increased investor confidence and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100